Bioanalytical Services
Global Leader in Biologics-focused Bioanalytical Solutions
Eurofins Pharma Bioanalytical Services, a division of Eurofins Clinical Trial Solutions, is a biologics-focused, global leader in bioanalytical solutions providing over 20 years of industry-leading scientific expertise. We specialize in comprehensive PK/TK, ADA, NAb, Biomarker assays and sample analysis for the world’s largest pharmaceutical and biopharmaceutical companies.
Our mission is to extend our clients' capabilities of improving global health by combining scientific knowledge, capacity, regulatory expertise, and flexibility to provide the trusted, relevant information required for the drug approval process.
SERVICES & SOLUTIONS
|
|
|
|
Immunogenicity >> |
Biomarkers >> |
Pharmacokinetics (PK)
|
Join our upcoming webinar with Cara Begg, Alliance Manager and Dr. Katryn Allen, Director of Business Development at Eurofins Clinical Trial Solutions to discover the comprehensive logistics of sample management and analysis across multiple global clinical trial sites. Our speakers will explore the general timelines and necessary steps from initial lab engagement to final data reporting. Plus, gain insights into regulatory assay requirements and the vital role of reagents in ensuring compliance. Participants will also learn about the needs of custom assay development projects, in support of pre-clinical or clinical studies.
Click here to watch this informative webinar to gain insights into the requirements and challenges of custom assay development, the benefits of partnering with a central lab for the execution of clinical trials, and the workflow and responsibilities from sample logistics to data reporting.
This discussion provides an overview of nanoString technology, as an innovative advancement in digital gene expression analysis. The unique features of this technology include enzyme-free digital gene expression analysis, a dual probe hybridization process, and digital analysis to provide accurate and quantitative measurement of RNA levels. This technology offers advantages over more common methods like qPCR and RNAseq, which will be detailed in the presentation. After imparting an understanding of the capabilities and advantages of the platform, the focus shifts to address many of the criteria and challenges considered in the process of its adoption by our laboratory. Subsequently, the narrative delves into how our laboratory is actively addressing these challenges to maximize the benefits of utilizing this technology to satisfy our clients' clinical testing needs and help advance their biopharmaceutical research.
Click here to access this presentation to explore how using the nanoString nCounter can help measure how different immunotherapy drugs work.
